{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:53:12Z","timestamp":1790009592624,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100008238","name":"Hebei Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["H2021206377"],"award-info":[{"award-number":["H2021206377"]}],"id":[{"id":"10.13039\/501100008238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-025-01899-6","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T10:48:12Z","timestamp":1766573292000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effects of high basal luteinizing hormone levels on in vitro fertilization\/intra-cytoplasmic injection outcomes in polycystic ovarian syndrome: a retrospective study"],"prefix":"10.1186","volume":"18","author":[{"given":"Hongfa","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guimin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7842-7301","authenticated-orcid":false,"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"1899_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yfrne.2017.05.002","volume":"46","author":"AM Moore","year":"2017","unstructured":"Moore AM, Campbell RE. Polycystic ovary syndrome: Understanding the role of the brain. Front Neuroendocrinol. 2017;46:1\u201314.","journal-title":"Front Neuroendocrinol"},{"key":"1899_CR2","doi-asserted-by":"crossref","unstructured":"Coutinho EA, Kauffman AS. The role of the brain in the pathogenesis and physiology of polycystic ovary syndrome (PCOS). Med Sci (Basel). 2019;7(8). https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31382541.","DOI":"10.3390\/medsci7080084"},{"issue":"3","key":"1899_CR3","doi-asserted-by":"publisher","first-page":"326","DOI":"10.4103\/jhrs.jhrs_105_21","volume":"14","author":"S Neeta","year":"2021","unstructured":"Neeta S, Neha M, Yogita D. Do basal luteinizing hormone and luteinizing hormone\/ Follicle-Stimulating hormone ratio have significance in prognosticating the outcome of in vitro fertilization cycles in polycystic ovary syndrome? J Hum Reprod Sci. 2021;14(3):326.","journal-title":"J Hum Reprod Sci"},{"issue":"5","key":"1899_CR4","doi-asserted-by":"publisher","first-page":"e16233","DOI":"10.1016\/j.heliyon.2023.e16233","volume":"9","author":"B Wang","year":"2023","unstructured":"Wang B, Li Z. Hypersecretion of basal luteinizing hormone and an increased risk of pregnancy loss among women with polycystic ovary syndrome undergoing controlled ovarian stimulation and intrauterine insemination. Heliyon. 2023;9(5):e16233.","journal-title":"Heliyon"},{"key":"1899_CR5","doi-asserted-by":"publisher","first-page":"1113840","DOI":"10.3389\/fmed.2023.1113840","volume":"10","author":"W Fu","year":"2023","unstructured":"Fu W, Kuang Y. Role of luteinizing hormone elevation in outcomes of ovulation induction with letrozole for polycystic ovary syndrome. Front Med (Lausanne). 2023;10:1113840.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"1899_CR6","doi-asserted-by":"publisher","first-page":"13835","DOI":"10.1038\/s41598-018-32128-4","volume":"8","author":"L Sun","year":"2018","unstructured":"Sun L, Ye J, Wang Y, Chen Q, Cai R, Fu Y, et al. Elevated basal luteinizing hormone does not impair the outcome of human menopausal gonadotropin and Medroxyprogesterone acetate treatment cycles. Sci Rep. 2018;8(1):13835.","journal-title":"Sci Rep"},{"issue":"1","key":"1899_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"EA-SPCWG Rotterdam","year":"2004","unstructured":"Rotterdam EA-SPCWG. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19\u201325.","journal-title":"Fertil Steril"},{"issue":"1","key":"1899_CR8","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1186\/s12884-023-05944-4","volume":"23","author":"Z Liu","year":"2023","unstructured":"Liu Z, Wang KH. Effect of basal luteinizing hormone (bLH) level on in vitro fertilization\/intra-cytoplasmic injections (IVF\/ICSI) outcomes in polycystic ovarian syndrome (PCOS) patients. BMC Pregnancy Childbirth. 2023;23(1):618.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"1899_CR9","doi-asserted-by":"publisher","first-page":"hoaa009","DOI":"10.1093\/hropen\/hoaa009","volume":"2020","author":"T Ovarian Stimulation","year":"2020","unstructured":"Ovarian Stimulation T, Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, et al. ESHRE guideline: ovarian stimulation for IVF\/ICSI(dagger). Hum Reprod Open. 2020;2020(2):hoaa009.","journal-title":"Hum Reprod Open"},{"key":"1899_CR10","doi-asserted-by":"crossref","unstructured":"Alpha Scientists in Reproductive M, Embryology ESIGo. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod. 2011;26(6):1270-83. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21502182.","DOI":"10.1016\/j.rbmo.2011.02.001"},{"issue":"3","key":"1899_CR11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.fertnstert.2017.06.005","volume":"108","author":"F Zegers-Hochschild","year":"2017","unstructured":"Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, et al. The International Glossary on Infertility and Fertility Care, 2017. Fertil Steril. 2017;108(3):393\u2013406.","journal-title":"Fertil Steril"},{"issue":"6","key":"1899_CR12","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/00006254-198906000-00004","volume":"44","author":"A Golan","year":"1989","unstructured":"Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Caspi E. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv. 1989;44(6):430\u201340.","journal-title":"Obstet Gynecol Surv"},{"key":"1899_CR13","doi-asserted-by":"publisher","first-page":"1429033","DOI":"10.3389\/fmed.2024.1429033","volume":"11","author":"M Aldarsooni","year":"2024","unstructured":"Aldarsooni M, Alfarah M, Albohammod F, Al-Jaroudi D. Effect of premature luteinizing hormone surge on pregnancy outcomes in intracytoplasmic sperm injection or in vitro fertilization cycles. Front Med (Lausanne). 2024;11:1429033.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"1899_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4103\/jhrs.JHRS_96_20","volume":"14","author":"N Singh","year":"2021","unstructured":"Singh N, Mishra N, Dogra Y. Do basal luteinizing hormone and luteinizing hormone\/Follicle-Stimulating hormone ratio have significance in prognosticating the outcome of in vitro fertilization cycles in polycystic ovary syndrome? J Hum Reprod Sci. 2021;14(1):21\u20137.","journal-title":"J Hum Reprod Sci"},{"issue":"8","key":"1899_CR15","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1093\/humrep\/17.8.2016","volume":"17","author":"P Humaidan","year":"2002","unstructured":"Humaidan P, Bungum L, Bungum M, Andersen CY. Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and Recombinant FSH stimulation. Hum Reprod. 2002;17(8):2016\u201321.","journal-title":"Hum Reprod"},{"issue":"1","key":"1899_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.fertnstert.2024.11.005","volume":"123","author":"JP Toner","year":"2025","unstructured":"Toner JP, Pirtea P. Luteinizing hormone\u2019s critical role in ovarian stimulation. Fertil Steril. 2025;123(1):31\u201340.","journal-title":"Fertil Steril"},{"issue":"10","key":"1899_CR17","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1093\/humrep\/del219","volume":"21","author":"R Lahoud","year":"2006","unstructured":"Lahoud R, Al-Jefout M, Tyler J, Ryan J, Driscoll G. A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF\/ICSI cycles leads to lower live birth rates. Hum Reprod. 2006;21(10):2645\u20139.","journal-title":"Hum Reprod"},{"issue":"4","key":"1899_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4103\/0974-1208.126285","volume":"6","author":"GA Raju","year":"2013","unstructured":"Raju GA, Chavan R, Deenadayal M, Gunasheela D, Gutgutia R, Haripriya G, et al. Luteinizing hormone and follicle stimulating hormone synergy: A review of role in controlled ovarian hyper-stimulation. J Hum Reprod Sci. 2013;6(4):227\u201334.","journal-title":"J Hum Reprod Sci"},{"issue":"1","key":"1899_CR19","doi-asserted-by":"publisher","first-page":"2409147","DOI":"10.1080\/09513590.2024.2409147","volume":"40","author":"Y Chen","year":"2024","unstructured":"Chen Y, Li Y, Li X, Liu L, Liu Z, Gui W, et al. Lower serum LH level was related to poor embryo quality and adverse pregnancy outcomes in fixed GnRH antagonist protocol with estradiol pretreatment. Gynecol Endocrinol. 2024;40(1):2409147.","journal-title":"Gynecol Endocrinol"},{"key":"1899_CR20","doi-asserted-by":"crossref","unstructured":"Liu MH, Liu S, Li LX, Wang P, Li HH, Li Y. LH levels May be used as an indicator for the time of antagonist administration in GnRH antagonist Protocols-A Proof-Of-Concept study. Front Endocrinol. 2019;10. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30809195.","DOI":"10.3389\/fendo.2019.00067"},{"key":"1899_CR21","doi-asserted-by":"publisher","first-page":"104850","DOI":"10.1016\/j.ebiom.2023.104850","volume":"97","author":"MSB Silva","year":"2023","unstructured":"Silva MSB, Decoster L, Delpouve G, Lhomme T, Ternier G, Prevot V, et al. Overactivation of GnRH neurons is sufficient to trigger polycystic ovary syndrome-like traits in female mice. EBioMedicine. 2023;97:104850.","journal-title":"EBioMedicine"},{"issue":"4","key":"1899_CR22","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/humrep\/dead012","volume":"38","author":"N Friis Wang","year":"2023","unstructured":"Friis Wang N, Bogstad JW, Pors SE, Petersen MR, Pinborg A, Yding Andersen C, et al. Eight weeks of androgen priming by daily low-dose hCG injections before ICSI treatment in women with low ovarian reserve. Hum Reprod. 2023;38(4):716\u201325.","journal-title":"Hum Reprod"},{"key":"1899_CR23","doi-asserted-by":"publisher","first-page":"141049","DOI":"10.1016\/j.scitotenv.2020.141049","volume":"745","author":"D Wang","year":"2020","unstructured":"Wang D, Weng Y, Zhang Y, Wang R, Wang T, Zhou J, et al. Exposure to hyperandrogen drives ovarian dysfunction and fibrosis by activating the NLRP3 inflammasome in mice. Sci Total Environ. 2020;745:141049.","journal-title":"Sci Total Environ"},{"issue":"5","key":"1899_CR24","doi-asserted-by":"publisher","first-page":"112391","DOI":"10.1016\/j.isci.2025.112391","volume":"28","author":"J Cai","year":"2025","unstructured":"Cai J, Zhu Q, Xiang Y, Weng L, Liang N, Hong X, et al. Hyperandrogenism triggers MtDNA release to participate in ovarian inflammation via mPTP\/cGAS\/STING in PCOS. iScience. 2025;28(5):112391.","journal-title":"iScience"},{"issue":"1","key":"1899_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/ijgo.12485","volume":"142","author":"Y Geng","year":"2018","unstructured":"Geng Y, Lai Q, Xun Y, Jin L. The effect of premature luteinizing hormone increases among high ovarian responders undergoing a gonadotropin-releasing hormone antagonist ovarian stimulation protocol. Int J Gynaecol Obstet. 2018;142(1):97\u2013103.","journal-title":"Int J Gynaecol Obstet"},{"key":"1899_CR26","doi-asserted-by":"publisher","first-page":"1411106","DOI":"10.3389\/fendo.2024.1411106","volume":"15","author":"CX Wei","year":"2024","unstructured":"Wei CX, Zhang JW, Xiang S, Lian F. Reproductive outcomes in fresh transfer cycles and antagonists with premature luteinizing and\/or progesterone surge: a single center retrospective cohort study. Front Endocrinol (Lausanne). 2024;15:1411106.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1899_CR27","doi-asserted-by":"publisher","first-page":"830567","DOI":"10.3389\/fendo.2022.830567","volume":"13","author":"X Luo","year":"2022","unstructured":"Luo X, Li L, Lin N, Ma R, Li Y, Wu Z. Low endogenous LH on the COS initiation day of a GnRH-Agonist regimen increases the risk of early pregnancy loss and adverse ART outcomes. Front Endocrinol (Lausanne). 2022;13:830567.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"1899_CR28","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4274\/jtgga.galenos.2024.2024-2-9","volume":"25","author":"N Kugelman","year":"2024","unstructured":"Kugelman N, Digby A, Rotshenker-Olshinka K, Bellemare V, Pooni A, Son WY, et al. Basal serum luteinizing hormone, total testosterone, and free testosterone levels do not impact IVF outcomes in patients with polycystic ovary syndrome. J Turk Ger Gynecol Assoc. 2024;25(4):192\u20139.","journal-title":"J Turk Ger Gynecol Assoc"},{"issue":"2","key":"1899_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.fertnstert.2019.10.014","volume":"113","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2020","unstructured":"Practice Committee of the American Society for Reproductive Medicine. Electronic address aao, practice committee of the American society for reproductive M. Evidence-based treatments for couples with unexplained infertility: a guideline. Fertil Steril. 2020;113(2):305\u201322.","journal-title":"Fertil Steril"},{"issue":"1","key":"1899_CR30","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1038\/s41598-022-08400-z","volume":"12","author":"S Kadoura","year":"2022","unstructured":"Kadoura S, Alhalabi M, Nattouf AH. Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF\/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis. Sci Rep. 2022;12(1):4456.","journal-title":"Sci Rep"},{"issue":"4","key":"1899_CR31","doi-asserted-by":"publisher","first-page":"265","DOI":"10.17772\/gp\/62205","volume":"87","author":"M Trenkic","year":"2016","unstructured":"Trenkic M, Popovic J, Kopitovic V, Bjelica A, Zivadinovic R, Pop-Trajkovic S. Flexible GnRH antagonist protocol vs. long GnRH agonist protocol in patients with polycystic ovary syndrome treated for IVF: comparison of clinical outcome and embryo quality. Ginekol Pol. 2016;87(4):265\u201370.","journal-title":"Ginekol Pol"},{"issue":"1","key":"1899_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/14647273.2018.1551630","volume":"23","author":"R Thaker","year":"2020","unstructured":"Thaker R, Mishra V, Gor M, Agarwal R, Sheth H, Kapadia P, et al. The role of stimulation protocol, number of oocytes retrieved with respect to follicular fluid oxidative stress and IVF outcome. Hum Fertil (Camb). 2020;23(1):23\u201331.","journal-title":"Hum Fertil (Camb)"},{"issue":"3","key":"1899_CR33","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/j.1447-0756.2010.01247.x","volume":"36","author":"MA Hosseini","year":"2010","unstructured":"Hosseini MA, Aleyasin A, Saeedi H, Mahdavi A. Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients. J Obstet Gynaecol Res. 2010;36(3):605\u201310.","journal-title":"J Obstet Gynaecol Res"},{"issue":"5","key":"1899_CR34","doi-asserted-by":"publisher","first-page":"400","DOI":"10.2174\/0118715303281640240722070348","volume":"25","author":"LJ Zhang","year":"2025","unstructured":"Zhang LJ, Liu D, Xu LQ, Wei JY, Fan L, Zhang XQ, et al. Impact of luteinizing hormone on IVF\/ICSI assisted reproduction on the initiation day of Gonadotropin-releasing hormone antagonist protocol. Endocr Metab Immune Disord Drug Targets. 2025;25(5):400\u201310.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"1899_CR35","doi-asserted-by":"publisher","first-page":"1481546","DOI":"10.3389\/fendo.2024.1481546","volume":"15","author":"H Verschuere","year":"2024","unstructured":"Verschuere H, Laenen A, Debrock S, Tomassetti C, Lie Fong S. Luteinizing hormone profiles during ovarian stimulation in assisted reproductive treatment. Front Endocrinol (Lausanne). 2024;15:1481546.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1899_CR36","first-page":"CD010290","volume":"1","author":"NS Weiss","year":"2019","unstructured":"Weiss NS, Kostova E, Nahuis M, Mol BWJ, van der Veen F, van Wely M. Gonadotrophins for ovulation induction in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2019;1(1):CD010290.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"1899_CR37","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmx017","volume":"23","author":"CB Lambalk","year":"2017","unstructured":"Lambalk CB, Banga FR, Huirne JA, Toftager M, Pinborg A, Homburg R, et al. GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type. Hum Reprod Update. 2017;23(5):560\u201379.","journal-title":"Hum Reprod Update"},{"issue":"5","key":"1899_CR38","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s12325-020-01612-7","volume":"38","author":"R Yang","year":"2021","unstructured":"Yang R, Guan Y, Perrot V, Ma J, Li R. Comparison of the Long-Acting GnRH agonist follicular protocol with the GnRH antagonist protocol in women undergoing in vitro fertilization: A systematic review and Meta-analysis. Adv Ther. 2021;38(5):2027\u201337.","journal-title":"Adv Ther"},{"issue":"2","key":"1899_CR39","first-page":"113","volume":"10","author":"Y Xu","year":"2019","unstructured":"Xu Y, Zhang YS, Zhu DY, Zhai XH, Wu FX, Wang AC. Influence of GnRH antagonist in reproductive women on in vitro fertilization and embryo transfer in fresh cycles. Biomed Rep. 2019;10(2):113\u20138.","journal-title":"Biomed Rep"},{"issue":"3","key":"1899_CR40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5653\/cerm.2018.45.3.135","volume":"45","author":"JJ Shin","year":"2018","unstructured":"Shin JJ, Park KE, Choi YM, Kim HO, Choi DH, Lee WS, et al. Early gonadotropin-releasing hormone antagonist protocol in women with polycystic ovary syndrome: A preliminary randomized trial. Clin Exp Reprod Med. 2018;45(3):135\u201342.","journal-title":"Clin Exp Reprod Med"},{"issue":"3","key":"1899_CR41","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/humrep\/dep436","volume":"25","author":"TG Lainas","year":"2010","unstructured":"Lainas TG, Sfontouris IA, Zorzovilis IZ, Petsas GK, Lainas GT, Alexopoulou E, et al. Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT). Hum Reprod. 2010;25(3):683\u20139.","journal-title":"Hum Reprod"},{"issue":"6","key":"1899_CR42","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/uog.15898","volume":"48","author":"M Kollmann","year":"2016","unstructured":"Kollmann M, Martins WP, Lima ML, Craciunas L, Nastri CO, Richardson A, et al. Strategies for improving outcome of assisted reproduction in women with polycystic ovary syndrome: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2016;48(6):709\u201318.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"1899_CR43","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/humrep\/dew051","volume":"31","author":"M Toftager","year":"2016","unstructured":"Toftager M, Bogstad J, Bryndorf T, Lossl K, Roskaer J, Holland T, et al. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF\/ICSI cycles. Hum Reprod. 2016;31(6):1253\u201364.","journal-title":"Hum Reprod"},{"key":"1899_CR44","doi-asserted-by":"publisher","first-page":"9424","DOI":"10.12659\/MSM.913757","volume":"24","author":"Y Chen","year":"2018","unstructured":"Chen Y, Zhao J, Zhang H. Comparative effectiveness of three ovarian hyperstimulation protocol in in vitro fertilization (IVF) cycles for women with polycystic ovary syndrome. Med Sci Monit. 2018;24:9424\u20138.","journal-title":"Med Sci Monit"},{"issue":"1","key":"1899_CR45","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12958-023-01120-7","volume":"21","author":"AM Kotlyar","year":"2023","unstructured":"Kotlyar AM, Seifer DB. Women with PCOS who undergo IVF: a comprehensive review of therapeutic strategies for successful outcomes. Reprod Biol Endocrinol. 2023;21(1):70.","journal-title":"Reprod Biol Endocrinol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01899-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01899-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01899-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T12:02:36Z","timestamp":1766577756000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-025-01899-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1899"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01899-6","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of the Second Hospital of Hebei Medical University (2023KY016). The requirement for written informed consent was waived by the board due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"302"}}